Integra LifeSciences Holdings Corporation provides revenue guidance for the second quarter of 2024. For the second quarter 2024, the Company expects reported revenues in the range of $411 million to $416 million, representing reported growth of 7.8% to 9.1% and organic growth of 1.3% to 2.6%.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.81 USD | +4.09% | +8.07% | -29.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.25% | 2.33B | |
-7.57% | 175B | |
-2.16% | 107B | |
-6.99% | 65.05B | |
-4.65% | 50.76B | |
+7.38% | 43.14B | |
+7.12% | 41.46B | |
+14.07% | 30.69B | |
+14.52% | 25.39B | |
-5.97% | 23.69B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter of 2024